|
1
|
Matsuoka R: Mutations of transcription
factors in human with heart disease for understanding the
development and mechanisms of congenital cardiovascular heart
disease. Adv Exp Med Biol. 565:349–415. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu H: Forkhead box transcription factors
in embryonic heart development and congenital heart disease. Life
Sci. 144:194–201. 2016. View Article : Google Scholar
|
|
3
|
Latchman DS: Transcription factors: An
overview. Int J Biochem Cell Biol. 29:1305–1312. 1997. View Article : Google Scholar
|
|
4
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shalgi R, Lieber D, Oren M and Pilpel Y:
Global and local architecture of the mammalian
microRNA-transcription factor regulatory network. PLoS Comput Biol.
3:e1312007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsang J, Zhu J and van Oudenaarden A:
MicroRNA-mediated feedback and feedforward loops are recurrent
network motifs in mammals. Mol Cell. 26:753–767. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li X, Cassidy JJ, Reinke CA, Fischboeck S
and Carthew RW: A microRNA imparts robustness against environmental
fluctuation during development. Cell. 137:273–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan Z, Shah PK, Amin SB, Samur MK, Huang
N, Wang X, Misra V, Ji H, Gabuzda D and Li C: Integrative analysis
of gene and miRNA expression profiles with transcription
factor-miRNA feed-forward loops identifies regulators in human
cancers. Nucleic Acids Res. 40:e1352012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang HM, Kuang S, Xiong X, Gao T, Liu C
and Guo AY: Transcription factor and microRNA co-regulatory loops:
Important regulatory motifs in biological processes and diseases.
Brief Bioinform. 16:45–58. 2015. View Article : Google Scholar
|
|
10
|
Mendis S, Davis S and Norrving B:
Organizational update: The world health organization global status
report on noncommunicable diseases 2014 one more landmark step in
the combat against stroke and vascular disease. Stroke.
46:e121–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maron BJ and Maron MS: Hypertrophic
cardiomyopathy. Lancet. 381:242–255. 2013. View Article : Google Scholar
|
|
12
|
Sala V, Gallo S, Leo C, Gatti S, Gelb BD
and Crepaldi T: Signaling to cardiac hypertrophy: Insights from
human and mouse RASopathies. Mol Med. 18:938–947. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diniz GP, Huang ZP, Liu J, Chen J, Ding J,
Fonseca RI, Barreto-Chaves ML, Donato J Jr, Hu X and Wang DZ: Loss
of microRNA-22 prevents high-fat diet induced dyslipidemia and
increases energy expenditure without affecting cardiac hypertrophy.
Clin Sci. 131:2885–2900. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heggermont WA, Papageorgiou AP, Quaegebeur
A, Deckx S, Carai P, Verhesen W, Eelen G, Schoors S, van Leeuwen R,
Alekseev S, et al: Inhibition of MicroRNA-146a and overexpression
of its target dihydrolipoyl succinyltransferase protect against
pressure overload-induced cardiac hypertrophy and dysfunction.
Circulation. 136:747–761. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagalingam RS, Sundaresan NR, Gupta MP,
Geenen DL, Solaro RJ and Gupta M: A cardiac-enriched microRNA,
miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J
Biol Chem. 292:51232017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shafei AE, Ali MA, Ghanem HG, Shehata AI,
Abdelgawad AA, Handal HR, Talaat KA, Ashaal AE and El-Shal AS:
Mesenchymal stem cells therapy: A promising cell based therapy for
treatment of myocardial infraction. J Gene Med. Dec;2017.Epub ahead
of print. View
Article : Google Scholar
|
|
17
|
Liang H, Qiu H and Tian L: Short-term
effects of fine particulate matter on acute myocardial infraction
mortality and years of life lost: A time series study in Hong Kong.
Sci Total Environ. 615:558–563. 2018. View Article : Google Scholar
|
|
18
|
Chen Y, Zhao Y, Chen W, Xie L, Zhao ZA,
Yang J, Chen Y, Lei W and Shen Z: MicroRNA-133 overexpression
promotes the therapeutic efficacy of mesenchymal stem cells on
acute myocardial infarction. Stem Cell Res Ther. 8:2682017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bayoumi AS, Park KM, Wang Y, Teoh JP,
Aonuma T, Tang Y, Su H, Weintraub NL and Kim IM: A
carvedilol-responsive microRNA, miR-125b-5p protects the heart from
acute myocardial infarction by repressing pro-apoptotic bak1 and
klf13 in cardiomyocytes. J Mol Cell Cardiol. 114:72–82. 2018.
View Article : Google Scholar
|
|
20
|
Liu X, Zhang Y, Du W, Liang H, He H, Zhang
L, Pan Z, Li X, Xu C, Zhou Y, et al: MiR-223-3p as a novel MicroRNA
regulator of expression of voltage-gated K+ channel Kv4.2 in acute
myocardial infarction. Cell Physiol Biochem. 39:102–114. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takeuchi T, Ishii Y, Kikuchi K and Hasebe
N: Ischemic preconditioning effect of prodromal angina is
attenuated in acute myocardial infarction patients with
hypertensive left ventricular hypertrophy. Circ J. 75:1192–1199.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esen O, Agus HZ, Guler GB, Açar G, Avci A,
Güler E, Karaca O, Geçmen C, Bulut M, Emiroğlu Y, et al:
Relationship between circulating soluble Fas ligand and preexisting
left ventricular hypertrophy in the setting of left ventricular
remodeling after acute myocardial infarction. Coron Artery Dis.
22:294–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aggarwal P, Turner A, Matter A, Kattman
SJ, Stoddard A, Lorier R, Swanson BJ, Arnett DK and Broeckel U: RNA
expression profiling of human iPSC-derived cardiomyocytes in a
cardiac hypertrophy model. PLoS One. 9:e1080512014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Lu M, Qiu C and Cui Q: TransmiR: A
transcription factor-microRNA regulation database. Nucleic Acids
Res. 38:D119–D122. 2010. View Article : Google Scholar
|
|
25
|
Vergoulis T, Vlachos IS, Alexiou P,
Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N,
Dalamagas T and Hatzigeorgiou AG: TarBase 6.0: Capturing the
exponential growth of miRNA targets with experimental support.
Nucleic Acids Res. 40:D222–D229. 2012. View Article : Google Scholar :
|
|
26
|
Aerts S, Lambrechts D, Maity S, Van Loo P,
Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan
B, et al: Gene prioritization through genomic data fusion. Nat
Biotechnol. 24:537–544. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang W, Mitra R, Lin CC, Wang Q, Cheng F
and Zhao Z: Systematic dissection of dysregulated transcription
factor-miRNA feed-forward loops across tumor types. Brief
Bioinform. 17:996–1008. 2016. View Article : Google Scholar
|
|
28
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu X, Wang S, Meng F, Wang J, Zhang Y,
Dai E, Yu X, Li X and Jiang W: SM2miR: A database of the
experimentally validated small molecules' effects on microRNA
expression. Bioinformatics. 29:409–411. 2013. View Article : Google Scholar
|
|
30
|
Wishart DS, Feunang YD, Guo AC, Lo EJ,
Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, et al:
DrugBank 5.0: A major update to the DrugBank database for 2018.
Nucleic Acids Res. 46:D1074–D1082. 2018. View Article : Google Scholar :
|
|
31
|
Amaral LA, Scala A, Barthelemy M and
Stanley HE: Classes of small-world networks. Proc Natl Acad Sci
USA. 97:11149–11152. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Simos T, Georgopoulou U, Thyphronitis G,
Koskinas J and Papaloukas C: Analysis of protein interaction
networks for the detection of candidate hepatitis B and C
biomarkers. IEEE J Biomed Health Inform. 19:181–189. 2015.
View Article : Google Scholar
|
|
33
|
Xu J, Li Y, Lu J, Pan T, Ding N, Wang Z,
Shao T, Zhang J, Wang L and Li X: The mRNA related ceRNA-ceRNA
landscape and significance across 20 major cancer types. Nucleic
Acids Res. 43:8169–8182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Indolfi C and Curcio A: Stargazing
microRNA maps a new miR-21 star for cardiac hypertrophy. J Clin
Invest. 124:1896–1898. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang Y, Cheng HW, Qiu Y, Dupee D, Noonan
M, Lin YD, Fisch S, Unno K, Sereti KI and Liao R: MicroRNA-34a
plays a key role in cardiac repair and regeneration following
myocardial infarction. Circ Res. 117:450–459. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He W, Huang H, Xie Q, Wang Z, Fan Y, Kong
B, Huang D and Xiao Y: MiR-155 knockout in fibroblasts improves
cardiac remodeling by targeting tumor protein p53-inducible nuclear
protein 1. J Cardiovasc Pharmacol Ther. 21:423–435. 2016.
View Article : Google Scholar
|
|
37
|
Liang J, Bai S, Su L, Li C, Wu J, Xia Z
and Xu D: A subset of circulating microRNAs is expressed
differently in patients with myocardial infarction. Mol Med Rep.
12:243–247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Y, Li Z, Liu T, Xue X, Jiang H, Huang
J and Wang H: Impaired cardioprotective function of transplantation
of mesenchymal stem cells from patients with diabetes mellitus to
rats with experimentally induced myocardial infarction. Cardiovasc
Diabetol. 12:402013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takehara N, Tsutsumi Y, Tateishi K, Ogata
T, Tanaka H, Ueyama T, Takahashi T, Takamatsu T, Fukushima M,
Komeda M, et al: Controlled delivery of basic fibroblast growth
factor promotes human cardiosphere-derived cell engraftment to
enhance cardiac repair for chronic myocardial infarction. J Am Coll
Cardiol. 52:1858–1865. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mir SA, Chatterjee A, Mitra A, Pathak K,
Mahata SK and Sarkar S: Inhibition of signal transducer and
activator of transcription 3 (STAT3) attenuates interleukin-6
(IL-6)-induced collagen synthesis and resultant hypertrophy in rat
heart. J Biol Chem. 287:2666–2677. 2012. View Article : Google Scholar :
|
|
41
|
Yue H, Li W, Desnoyer R and Karnik SS:
Role of nuclear unphosphorylated STAT3 in angiotensin II type 1
receptor-induced cardiac hypertrophy. Cardiovasc Res. 85:90–99.
2010. View Article : Google Scholar
|
|
42
|
Yang CH, Yue J, Fan M and Pfeffer LM: IFN
induces miR-21 through a signal transducer and activator of
transcription 3-dependent pathway as a suppressive negative
feedback on IFN-induced apoptosis. Cancer Res. 70:8108–8116. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ivey KN and Srivastava D: MicroRNAs as
regulators of differentiation and cell fate decisions. Cell Stem
Cell. 7:36–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fang Z, Xu C, Li Y, Cai X, Ren S, Liu H,
Wang Y, Wang F, Chen R, Qu M, et al: A feed-forward regulatory loop
between androgen receptor and PlncRNA-1 promotes prostate cancer
progression. Cancer Lett. 374:62–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
